Detalles de la búsqueda
1.
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy.
J Infect Dis
; 227(12): 1376-1380, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36763044
2.
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
Clin Infect Dis
; 71(7): e170-e177, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724034
3.
Viral hepatitis B and C in HIV-exposed South African infants.
BMC Pediatr
; 20(1): 563, 2020 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357228
4.
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
Antimicrob Agents Chemother
; 59(6): 3399-405, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25824215
5.
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
J Pediatric Infect Dis Soc
; 10(2): 201-204, 2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32448902
6.
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings.
AIDS
; 35(9): 1439-1449, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33831905
7.
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome.
Int J Infect Dis
; 84: 30-38, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31009738
8.
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
AIDS
; 33(14): 2197-2203, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31689263
9.
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052.
J Acquir Immune Defic Syndr
; 77(5): 484-491, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29293156
10.
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.
J Acquir Immune Defic Syndr
; 72(3): 304-9, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26859828
11.
The "structurally minimal" isoform KChIP2d modulates recovery of K(v)4.3 N-terminal deletion mutant Δ2-39.
Channels (Austin)
; 5(3): 225-7, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21422811
12.
K(V)4.3 N-terminal deletion mutant Δ2-39: effects on inactivation and recovery characteristics in both the absence and presence of KChIP2b.
Channels (Austin)
; 5(1): 43-55, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21057209
13.
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings
Artículo
en Inglés
| ARCA | ID: arc-50344
14.
15.
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
Artículo
en Inglés
| ARCA | ID: arc-23739
16.
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
No convencional
en Inglés
| ARCA | ID: arc-29102
17.
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
Preprint
en Inglés
| PREPRINT-FIOCRUZ | ID: ppf-29102
Resultados
1 -
17
de 17
1
Próxima >
>>